Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation.

Cao H, Yu R, Choi Y, Ma ZZ, Zhang H, Xiang W, Lee DY, Berman BM, Moudgil KD, Fong HH, van Breemen RB.

Pharmacol Res. 2010 Jun;61(6):519-24. doi: 10.1016/j.phrs.2010.02.007. Epub 2010 Feb 24.

2.

Comparative pharmacokinetic study of two boswellic acids in normal and arthritic rat plasma after oral administration of Boswellia serrata extract or Huo Luo Xiao Ling Dan by LC-MS.

Wang H, Zhang C, Wu Y, Ai Y, Lee DY, Dai R.

Biomed Chromatogr. 2014 Oct;28(10):1402-8. doi: 10.1002/bmc.3182. Epub 2014 May 8.

PMID:
24806456
3.
4.

Houttuynia cordata, a novel and selective COX-2 inhibitor with anti-inflammatory activity.

Li W, Zhou P, Zhang Y, He L.

J Ethnopharmacol. 2011 Jan 27;133(2):922-7. doi: 10.1016/j.jep.2010.10.048. Epub 2010 Nov 10.

PMID:
21073936
5.
6.

Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids.

Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, Schneider G, Jauch J, Poeckel D, Werz O.

Biochem Pharmacol. 2008 Jan 15;75(2):503-13. Epub 2007 Sep 14.

PMID:
17945191
7.

Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I, et al.

J Pharmacol Exp Ther. 1999 Aug;290(2):551-60.

8.

N-Caffeoyl serotonin as selective COX-2 inhibitor.

Takahashi T, Miyazawa M.

Bioorg Med Chem Lett. 2012 Apr 1;22(7):2494-6. doi: 10.1016/j.bmcl.2012.02.002. Epub 2012 Feb 9.

PMID:
22386242
9.

The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.

Li L, Ji H, Sheng L, Zhang Y, Lai Y, Chen X.

Eur J Pharmacol. 2009 Apr 1;607(1-3):244-50. doi: 10.1016/j.ejphar.2009.02.032. Epub 2009 Feb 23.

PMID:
19243697
10.

Evaluation of cyclooxygenase-2 inhibitors using pulsed ultrafiltration mass spectrometry.

Nikolic D, Habibi-Goudarzi S, Corley DG, Gafner S, Pezzuto JM, van Breemen RB.

Anal Chem. 2000 Aug 15;72(16):3853-9.

PMID:
10959973
11.

Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels.

Kase Y, Saitoh K, Ishige A, Komatsu Y.

Biol Pharm Bull. 1998 Dec;21(12):1277-81.

PMID:
9881638
12.

Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.

Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ, Koboldt CM, Muhammad JL, Zweifel BS, Masferrer JL, Isakson PC, Seibert K.

J Pharmacol Exp Ther. 2005 Mar;312(3):1206-12. Epub 2004 Oct 19.

13.

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.

Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC, et al.

Br J Pharmacol. 1997 May;121(1):105-17.

14.

Anti-inflammatory activity of Chinese medicinal vine plants.

Li RW, David Lin G, Myers SP, Leach DN.

J Ethnopharmacol. 2003 Mar;85(1):61-7.

PMID:
12576203
15.

Redox and non-redox mechanism of in vitro cyclooxygenase inhibition by natural quinones.

Landa P, Kutil Z, Temml V, Vuorinen A, Malik J, Dvorakova M, Marsik P, Kokoska L, Pribylova M, Schuster D, Vanek T.

Planta Med. 2012 Mar;78(4):326-33. doi: 10.1055/s-0031-1280430. Epub 2011 Dec 15.

PMID:
22174077
16.

Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.

Lu ZH, Xiong XY, Zhang BL, Lin GC, Shi YX, Liu ZG, Meng JR, Zhou YM, Mei QB.

Acta Pharmacol Sin. 2005 Dec;26(12):1505-11.

17.

Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.

Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA.

Br J Pharmacol. 1997 May;121(1):125-33.

18.

Anti-inflammatory acylphloroglucinol derivatives from Hops (Humulus lupulus).

Bohr G, Gerhäuser C, Knauft J, Zapp J, Becker H.

J Nat Prod. 2005 Oct;68(10):1545-8.

PMID:
16252923
19.

Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.

Perissutti E, Fiorino F, Renner C, Severino B, Roviezzo F, Sautebin L, Rossi A, Cirino G, Santagada V, Caliendo G.

J Med Chem. 2006 Dec 28;49(26):7774-80.

PMID:
17181159
20.

Supplemental Content

Support Center